Home / Providers
Licensed providers

Ro, Found, and Sequence: same category, different bet

All three connect you with a licensed clinician who can prescribe a GLP-1. Where they differ is how much you pay, what's bundled into that price, and how much coaching comes with it.

Short version: Ro leans on its own pharmacy and offers the widest brand-name formulary. Found bundles behavioral coaching into a lower membership fee, with medication billed separately. Sequence (WeightWatchers) is physician-led and works best if your insurance already covers the medication — its cash-pay price is the highest of the three.
Compare

What each one actually charges

Pricing structures aren't apples to apples — some separate a membership fee from medication cost, some don't. Figures below are commonly reported ranges as of mid-2026 and change often. Confirm the current total before enrolling.

Ro
Widest formulary
Starting price$145+/mo
Medications offeredSemaglutide, tirzepatide (brand + compounded)
Clinical modelVideo visits, own pharmacy, Quest lab access
InsuranceAccepted where eligible
Get started with Ro →

Runs its own licensed pharmacy, giving more direct control over fulfillment. Medication pricing tends to sit $50–100/mo above the lowest-cost providers.

Found
Membership~$99/mo
Medication (separate)~$149–249/mo
Clinical modelBehavioral coaching + prescribing
InsuranceAccepted where eligible
Get started with Found →

Membership and medication are billed separately — the advertised membership price alone isn't the total monthly cost. Best fit if structured behavioral coaching matters to you.

Sequence
Best with insurance
Starting price~$179–349/mo
With insurance coverage~$74/mo + copay
Clinical modelObesity-medicine physician-led, WeightWatchers ecosystem
InsuranceAccepted where eligible
Get started with Sequence →

Cash-pay price is the highest of the three, and some plans require a longer initial commitment. Makes the most sense when your insurance already covers the medication.

Who each one fits

Picking between them

Choose Ro if

  • You want access to both semaglutide and tirzepatide brand-name options in one place
  • You'd rather have labs ordered directly through the platform than coordinate separately
  • You're comfortable paying a bit more for an established pharmacy pipeline

Choose Found or Sequence if

  • Structured coaching alongside medication matters to your success, not just the prescription itself
  • (Sequence specifically) your insurance already covers the medication — the cash-pay price is easier to justify with coverage
  • You want a longer-term program structure rather than a bare-bones prescribing service
FAQ

Common questions

Are these prices for compounded or brand-name medication?

It depends on the provider and plan tier. Ro offers both brand-name and compounded options. Found and Sequence's pricing above assumes brand-name prescribing through insurance or manufacturer savings programs where eligible — always confirm which formulation a quoted price covers before enrolling.

Do any of these guarantee insurance coverage?

No. None of these platforms can guarantee your specific plan will cover a GLP-1 — that depends on your insurer's formulary and prior authorization criteria. What they can do is submit the prior authorization on your behalf and tell you what your plan actually requires.

Can I switch providers if one doesn't work out?

Generally yes, though contract terms vary — some programs (Sequence, historically) have used longer initial commitment periods. Read the cancellation terms before enrolling, particularly for any plan with an upfront or annual charge.

Medical disclaimer: This page is for general information and isn't a substitute for professional medical advice. Every provider listed employs licensed clinicians who evaluate you before prescribing anything.

Advertising disclosure: DosageBuzz has affiliate partnerships with some telehealth providers linked on this page, including Ro, Found, and Sequence. We may earn a commission if you sign up through these links, at no additional cost to you. This doesn't affect how we present pricing or clinical information.